Open access · CC-BY
via OpenAlex
Alpha-Synuclein Aggregation in Parkinson's Disease
E. Srinivasan, G. Chandrasekhar, P. Chandrasekar, K. Anbarasu, Agaram Sundaram Vickram, Rohini Karunakaran, Ramalingam Rajasekaran, Padmalayam Sadanandan Srikumar
Frontiers in Medicine · 2021 · ▲ 253 citations
Abstract
Parkinson's disease (PD), a neurodegenerative disorder characterized by distinct aging-independent loss of dopaminergic neurons in substantia nigra pars compacta (SNpc) region urging toward neuronal loss. Over the decade, various key findings from clinical perspective to molecular pathogenesis have aided in understanding the genetics with assorted genes related with PD. Subsequently, several pathways have been incriminated in the pathogenesis of PD, involving mitochondrial dysfunction(definition), protein aggregation, and misfolding. On the other hand, the sporadic form of PD cases is found with no genetic linkage, which still remain an unanswered question? The exertion in ascertaining vulnerability factors in PD considering the genetic factors are to be further dissevered in the forthcoming decades with advancement in research studies. One of the major proponents behind the prognosis of PD is the pathogenic transmutation of aberrant alpha-synuclein protein into amyloid fibrillar structures, which actuates neurodegeneration. Alpha-synuclein, transcribed by SNCA gene is a neuroprotein found predominantly in brain. It is implicated in the modulation of synaptic vesicle transport and eventual release of neurotransmitters. Due to genetic mutations and other elusive factors, the alpha-synuclein misfolds into its amyloid form. Therefore, this review aims in briefing the molecular understanding of the alpha-synuclein associated with PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fmed.2021.736978
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Srinivasan, E., Chandrasekhar, G., Chandrasekar, P., Anbarasu, K., Vickram, A.S., Karunakaran, R., Rajasekaran, R., & Srikumar, P.S. (2021). Alpha-Synuclein Aggregation in Parkinson's Disease. <em>Frontiers in Medicine</em>. https://doi.org/10.3389/fmed.2021.736978
Vancouver
Srinivasan E, Chandrasekhar G, Chandrasekar P, Anbarasu K, Vickram AS, Karunakaran R, et al. Alpha-Synuclein Aggregation in Parkinson's Disease. Frontiers in Medicine. 2021. doi:10.3389/fmed.2021.736978.
BibTeX
@article{e2021AlphaS,
title = {Alpha-Synuclein Aggregation in Parkinson's Disease},
author = {E. Srinivasan and G. Chandrasekhar and P. Chandrasekar and K. Anbarasu and Agaram Sundaram Vickram and Rohini Karunakaran and Ramalingam Rajasekaran and Padmalayam Sadanandan Srikumar},
journal = {Frontiers in Medicine},
year = {2021},
doi = {10.3389/fmed.2021.736978},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuroscience Letters 2017
Citation only
Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s Disease
Autophagy 2008
Open access · OA
Alpha-synuclein degradation by autophagic pathways: A potential key to Parkinson’s Disease pathogenesis
The Journals of Gerontology Series A 2011
Open access · OA
Exploring Biologically Relevant Pathways in Frailty
Cellular and Molecular Neurobiology 2025
Open access · CC-BY
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’s Disease
Frontiers in Aging Neuroscience 2020
Open access · CC-BY
Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease
Expert Review of Proteomics 2008
Citation only